Analyst Research

Report Title Price
Provider: Pechala's Reports
Provider: Reuters Investment Profile
Provider: Thomson Reuters StreetEvents
Provider: Thomson Reuters StreetEvents

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aldeyra Therapeutics Inc files IPO - Form S-1/A

Monday, 7 Apr 2014 05:30pm EDT 

Aldeyra Therapeutics Inc:Says it is offering all of the shares of common stock offered by this prospectus.Says it is offering 2,275,000 shares of common stock.Public offering price of shares of common stock to be between $10.00 and $12.00 per share.Common stock has been approved for listing on The NASDAQ Capital Market under the symbol ALDX.Intends to use net proceeds for research and development activities, including planned clinical trials of NS2, to develop aldehyde traps for the treatment of other diseases and for working capital and other general corporate purposes. 

Company Quote

0.21 +2.87%
24 Dec 2014